ADXN 6-K: SEC filing
Addex Therapeutics
Filed with the SEC on · accession 0001171843-26-007354
ADXN filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. Addex Therapeutics filed a Form 6-K announcing that it issued a press release on November 11, 2026, which is attached as Exhibit 99.1 and incorporated by reference into its registration statements. The stock moved +61.9% by the first close after the filing.
Summary of the filing
Addex Therapeutics filed a Form 6-K announcing that it issued a press release on November 11, 2026, which is attached as Exhibit 99.1 and incorporated by reference into its registration statements. The filing text does not disclose the specific contents of the press release.
Key details
How ADXN stock reacted
Close before
$2.89
Nov 11, 2026
First close after
+61.94%
$4.68
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ADXN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ADXN?
Click hereFrequently asked questions
What did ADXN file with the SEC on Nov 12, 2026?
ADXN filed a 6-K (SEC filing). Addex Therapeutics filed a Form 6-K announcing that it issued a press release on November 11, 2026, which is attached as Exhibit 99.1 and incorporated by reference into its registration statements. The filing text does not disclose the specific contents of the press release.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did ADXN stock react to this filing?
ADXN closed at $2.89 before the filing and $4.68 on Nov 12, 2026 (+61.94%).
Other ADXN SEC filings
- 6-K · SEC filingOct 29, 2026
- 6-K · Fda approvalOct 8, 2026
- 6-K · Executive departureOct 2, 2026
- 6-K · SEC filingSep 28, 2026
- 6-K · Contract winSep 25, 2026
- SCHEDULE 13D/A · SEC filingSep 4, 2026
- SCHEDULE 13D/A · SEC filingAug 27, 2026
- 6-K · Secondary offeringAug 26, 2026
- 6-K · Fda approvalJul 8, 2026
- 6-K · SEC filingJun 30, 2026
Get alerts when ADXN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days